Faculty Opinions recommendation of Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
2012 ◽
Vol 344
(1)
◽
pp. 196-206
◽
2014 ◽
Vol 109
(10)
◽
pp. 1547-1561
◽
2020 ◽
Vol 115
(4)
◽
pp. 596-602
◽
2020 ◽
Vol 115
(1)
◽
pp. S245-S246
2016 ◽
Vol 20
(3)
◽
pp. 273-279
◽
2015 ◽
Vol 110
◽
pp. S758
2008 ◽
Vol 2
(4)
◽
pp. 497-508
◽
2015 ◽
Vol 35
(6)
◽
pp. 613-630
◽